Replies to post #10815 on Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

Will Teva increase the Copaxone price by another 10% + in early 2014 (prior to any generic launch in late May - just as they have done every year for the last decade plus)?

Almost certainly yes. The regular price increases for other MS drugs in the US market give Teva ample cover to raise the price of Copaxone again.